I have been wondering what Stamler will present in his AAN poster about the randomized ATH434 study because there are no results to present and the baseline is somehow not worth publishing, IMO.
The title is: "A Phase 2 Study of ATH434, a Novel Inhibitor of α-Synuclein Aggregation, for the Treatment of Multiple System Atrophy (MSA)".
Now I found ( only in my opinion ) the reason: He is not talking about an iron chelator but about " an inhibitor of α-Synuclein Aggregation". Iron chelation with deferiprone made Parkinson's patients worse and so iron chelation may have a poor reputation. Perhaps he is talking about all the previous animal experiments in which ATH434 was demonstrated as an inhibitor of α-Synuclein Aggregation.
For this "Inhibition talk," he has a lot of interesting things to tell. ATH434 is very different from Deferiprone despite it being an iron chelator. This was already presented a few months ago in a smaller meeting but in the AAN meeting and connected to the started phase 2 study it is sure worth presenting.
Here is the poster by Kosman et al demonstrating how ATH434 works and protects the mitochondria:
https://alteritytherapeutics.com/wp-content/uploads/Society-for-Neuroscience-2023_poster.pdf
Inhibition of alpha-synuclein aggregation is the important thing big pharma and neurologists need to treat both MSA and PD.
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting
Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting, page-10
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126437200 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.003 |
56 | 89498098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126437200 | 27 |
0.005 | 29143782 | 28 |
0.006 | 12098927 | 17 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online